International ME/CFS Conference 2026 >

Speakers and Chairs >

Gunnar Gottschalk

Profile

Dr (PhD) Gunnar Gottschalk

Simmaron Research, USA

Presentation

11:15 CEST / Session: Treatment II: Clinical trials targeting immune dysregulation

Low-dose Rapamycin in ME/CFS and PCS

Details on this speaker/chair will be published soon.

Gunnar Gottschalk

More Information

Speakers

Agenda

International Declaration